{"transactions":[{"id":738728,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-15T23:48:40.000Z","date":"2026-06-15","kind":"sale","planned":false,"acquired":false,"shares":18160,"price":5.7101,"value":103695.416,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.68 to $5.73 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":119562,"source":{"system":"sec-edgar","filing":"0001493152-26-028777","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226028777/ownership.xml","form_type":"4"}},{"id":920305,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-04T21:30:06.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":20070,"price":5.0906,"value":102168.342,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.09 to $5.12 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":137722,"source":{"system":"sec-edgar","filing":"0001493152-26-005106","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226005106/ownership.xml","form_type":"4"}},{"id":930630,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-27T21:30:24.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":37313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on January 26, 2027."}],"balance_after":157792,"source":{"system":"sec-edgar","filing":"0001493152-26-003807","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226003807/ownership.xml","form_type":"4"}},{"id":1089822,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-10T20:30:40.000Z","date":"2025-07-09","kind":"sale","planned":false,"acquired":false,"shares":13093,"price":5.8557,"value":76668.6801,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.78 to $5.92 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":120479,"source":{"system":"sec-edgar","filing":"0001641172-25-018605","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225018605/ownership.xml","form_type":"4"}},{"id":1273622,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:10:36.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":32400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":5.94,"expiration_date":"2033-01-26","underlying":"Common Stock","underlying_shares":32400},"source":{"system":"sec-edgar","filing":"0001104659-25-011238","document":"tm255946-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465925011238/tm255946-1_4seq1.xml","form_type":"4"}},{"id":1273621,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:10:36.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":9.74,"expiration_date":"2034-01-18","underlying":"Common Stock","underlying_shares":20900},"source":{"system":"sec-edgar","filing":"0001104659-25-011238","document":"tm255946-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465925011238/tm255946-1_4seq1.xml","form_type":"4"}},{"id":1273620,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:10:36.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":1.4,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":10450},"source":{"system":"sec-edgar","filing":"0001104659-25-011238","document":"tm255946-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465925011238/tm255946-1_4seq1.xml","form_type":"4"}},{"id":1273619,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-11T09:10:36.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4702,"price":0.55,"value":2586.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 29, 2024, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Immedica Pharma AB, a corporation organized and existing under the laws of Sweden (\"Parent\"), and Matador Subsidiary, Inc. a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $0.55 per share (the \"Offer Price\") in cash."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents 4,702 shares underlying Restricted Stock Units (the \"RSUs\"). Pursuant to the terms of the Merger Agreement, at the effective time of the merger (the \"Effective Time\"), each outstanding RSU was terminated in exchange for a lump sum cash payment equal to (i) the Offer Price multiplied by (ii) the number of shares of Common Stock underlying the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 29, 2024, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Immedica Pharma AB, a corporation organized and existing under the laws of Sweden (\"Parent\"), and Matador Subsidiary, Inc. a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $0.55 per share (the \"Offer Price\") in cash."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-011238","document":"tm255946-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465925011238/tm255946-1_4seq1.xml","form_type":"4"}},{"id":1273618,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-11T09:10:36.000Z","date":"2025-02-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9398,"price":0.55,"value":5168.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 29, 2024, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Immedica Pharma AB, a corporation organized and existing under the laws of Sweden (\"Parent\"), and Matador Subsidiary, Inc. a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $0.55 per share (the \"Offer Price\") in cash."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 29, 2024, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Immedica Pharma AB, a corporation organized and existing under the laws of Sweden (\"Parent\"), and Matador Subsidiary, Inc. a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $0.55 per share (the \"Offer Price\") in cash."}],"balance_after":4702,"source":{"system":"sec-edgar","filing":"0001104659-25-011238","document":"tm255946-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465925011238/tm255946-1_4seq1.xml","form_type":"4"}},{"id":1288476,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-04T01:37:41.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":36101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon vesting, a portion of the restricted stock may be surrendered to satisfy the reporting person's tax withholding obligation. Any deemed disposition of the withheld shares would be exempt pursuant to Rule 16b-3(e)."},{"field":"shares","element":"transactionShares","label":"F2","text":"All of the restricted stock will vest on January 31, 2026."}],"balance_after":133572,"source":{"system":"sec-edgar","filing":"0001493152-25-004752","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225004752/ownership.xml","form_type":"4"}},{"id":1422647,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-27T23:09:32.000Z","date":"2024-08-26","kind":"grant","planned":false,"acquired":true,"shares":11797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The acquisition was exempt pursuant to Rule 16b-3(d)."},{"field":"shares","element":"transactionShares","label":"F2","text":"This stock grant represents the remainder of the 2024 annual grant to board of directors. This portion of the annual stock grant\nwas withheld until all employees/management were allocated their shares and in order to enable onboarding of two new Board\nmembers. All of the restricted stock will vest on August 26, 2025."}],"balance_after":97471,"source":{"system":"sec-edgar","filing":"0001493152-24-034056","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224034056/ownership.xml","form_type":"4"}},{"id":1458009,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-09T20:35:38.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":23611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on July 8, 2025."}],"balance_after":85674,"source":{"system":"sec-edgar","filing":"0001493152-24-026647","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224026647/ownership.xml","form_type":"4"}},{"id":1473976,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T20:30:15.000Z","date":"2024-06-18","kind":"sale","planned":false,"acquired":false,"shares":25821,"price":4.51,"value":116452.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $4.47 to $4.55 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":62063,"source":{"system":"sec-edgar","filing":"0001493152-24-024527","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224024527/ownership.xml","form_type":"4"}},{"id":1472974,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T16:27:33.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":10450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in full on July 15, 2025, subject to the reporting person's continued service with the Issuer."}],"balance_after":10450,"derivative":{"exercise_price":1.4,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":10450},"source":{"system":"sec-edgar","filing":"0001415889-24-017643","document":"form4-06202024_080629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000141588924017643/form4-06202024_080629.xml","form_type":"4"}},{"id":1472973,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T16:27:33.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":2300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). The RSUs vest in full on July 15, 2025, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer."}],"balance_after":14100,"source":{"system":"sec-edgar","filing":"0001415889-24-017643","document":"form4-06202024_080629.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000141588924017643/form4-06202024_080629.xml","form_type":"4"}},{"id":1675084,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-19T16:27:09.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":20900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in 12 equal monthly installments beginning on February 18, 2024, subject to the reporting person's continued service with the Issuer."}],"balance_after":20900,"derivative":{"exercise_price":9.74,"expiration_date":"2034-01-18","underlying":"Common Stock","underlying_shares":20900},"source":{"system":"sec-edgar","filing":"0001415889-24-001602","document":"form4-01192024_090103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000141588924001602/form4-01192024_090103.xml","form_type":"4"}},{"id":1675083,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-19T16:27:09.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). The RSUs vest in full on January 18, 2025, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer."}],"balance_after":11800,"source":{"system":"sec-edgar","filing":"0001415889-24-001602","document":"form4-01192024_090103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000141588924001602/form4-01192024_090103.xml","form_type":"4"}},{"id":1771881,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-29T20:30:28.000Z","date":"2023-09-27","kind":"sale","planned":false,"acquired":false,"shares":6330,"price":3.9054,"value":24721.182,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $3.8200 to $4.2000 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":87884,"source":{"system":"sec-edgar","filing":"0001493152-23-034858","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223034858/ownership.xml","form_type":"4"}},{"id":1853509,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:05:25.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":58689,"price":4.62,"value":271143.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on June 14, 2024."}],"balance_after":94214,"source":{"system":"sec-edgar","filing":"0001493152-23-021648","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223021648/ownership.xml","form_type":"4"}},{"id":2042025,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-30T16:15:25.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":32400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in 36 equal monthly installments beginning on February 26, 2023, subject to the reporting person's continued service with the Issuer."}],"balance_after":32400,"derivative":{"exercise_price":5.94,"expiration_date":"2033-01-26","underlying":"Common Stock","underlying_shares":32400},"source":{"system":"sec-edgar","filing":"0001415889-23-001546","document":"form4-01302023_090103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000141588923001546/form4-01302023_090103.xml","form_type":"4"}},{"id":2042024,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-30T16:15:25.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":7200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). The RSUs will vest in three equal annual installments, with the first installment vesting on January 26, 2024, the second installment vesting on January 26, 2025 and the third installment vesting on January 26, 2026, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer).  Each RSU represents the right to receive one share of common stock of the Issuer."}],"balance_after":7200,"source":{"system":"sec-edgar","filing":"0001415889-23-001546","document":"form4-01302023_090103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000141588923001546/form4-01302023_090103.xml","form_type":"4"}},{"id":2150198,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-28T20:38:43.000Z","date":"2022-09-26","kind":"grant","acquired":true,"shares":13400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on September 26, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split."}],"balance_after":35525,"source":{"system":"sec-edgar","filing":"0001493152-22-027051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222027051/ownership.xml","form_type":"4"}},{"id":2694354,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-28T01:45:42.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":49084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the stock options will vest on November 25, 2021."}],"balance_after":49084,"derivative":{"exercise_price":1.49,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":49084},"source":{"system":"sec-edgar","filing":"0001493152-21-013121","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221013121/ownership.xml","form_type":"4"}},{"id":2694353,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T01:45:42.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":38590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on November 25, 2021."}],"balance_after":118590,"source":{"system":"sec-edgar","filing":"0001493152-21-013121","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221013121/ownership.xml","form_type":"4"}},{"id":2972248,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:14.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":93750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, January 7, 2019, December 14, 2017, December 13, 2016 and May 2, 2016 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vest 25% on May 2, 2017, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":2.69,"expiration_date":"2026-05-02","underlying":"Common Stock","underlying_shares":93750},"source":{"system":"sec-edgar","filing":"0001493152-20-022149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022149/ownership.xml","form_type":"4"}},{"id":2972247,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:14.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":93750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, January 7, 2019, December 14, 2017, December 13, 2016 and May 2, 2016 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vest 25% on May 2, 2017, and in 36 equal monthly installments thereafter."}],"balance_after":93750,"derivative":{"exercise_price":1.28,"expiration_date":"2026-05-02","underlying":"Common Stock","underlying_shares":93750},"source":{"system":"sec-edgar","filing":"0001493152-20-022149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022149/ownership.xml","form_type":"4"}},{"id":2972246,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:14.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, January 7, 2019, December 14, 2017, December 13, 2016 and May 2, 2016 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vest 25% on December 13, 2017, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":4.45,"expiration_date":"2026-12-13","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-20-022149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022149/ownership.xml","form_type":"4"}},{"id":2972245,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:14.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, January 7, 2019, December 14, 2017, December 13, 2016 and May 2, 2016 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vest 25% on December 13, 2017, and in 36 equal monthly installments thereafter."}],"balance_after":75000,"derivative":{"exercise_price":1.28,"expiration_date":"2026-12-13","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-20-022149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022149/ownership.xml","form_type":"4"}},{"id":2972244,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:14.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, January 7, 2019, December 14, 2017, December 13, 2016 and May 2, 2016 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest 25% on December 14, 2018, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2027-12-14","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001493152-20-022149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022149/ownership.xml","form_type":"4"}},{"id":2972243,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:14.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, January 7, 2019, December 14, 2017, December 13, 2016 and May 2, 2016 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest 25% on December 14, 2018, and in 36 equal monthly installments thereafter."}],"balance_after":35000,"derivative":{"exercise_price":1.28,"expiration_date":"2027-12-14","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001493152-20-022149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022149/ownership.xml","form_type":"4"}},{"id":2972242,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:14.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, January 7, 2019, December 14, 2017, December 13, 2016 and May 2, 2016 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest 25% on January 7, 2020, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":7.02,"expiration_date":"2029-01-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-20-022149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022149/ownership.xml","form_type":"4"}},{"id":2972241,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:14.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, January 7, 2019, December 14, 2017, December 13, 2016 and May 2, 2016 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest 25% on January 7, 2020, and in 36 equal monthly installments thereafter."}],"balance_after":20000,"derivative":{"exercise_price":1.28,"expiration_date":"2029-01-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-20-022149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022149/ownership.xml","form_type":"4"}},{"id":2972240,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:14.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, January 7, 2019, December 14, 2017, December 13, 2016 and May 2, 2016 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":7.24,"expiration_date":"2029-04-09","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001493152-20-022149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022149/ownership.xml","form_type":"4"}},{"id":2972239,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:14.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, January 7, 2019, December 14, 2017, December 13, 2016 and May 2, 2016 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter."}],"balance_after":80000,"derivative":{"exercise_price":1.28,"expiration_date":"2029-04-09","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001493152-20-022149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022149/ownership.xml","form_type":"4"}},{"id":2972238,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:14.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":102163,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, January 7, 2019, December 14, 2017, December 13, 2016 and May 2, 2016 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.45,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":102163},"source":{"system":"sec-edgar","filing":"0001493152-20-022149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022149/ownership.xml","form_type":"4"}},{"id":2972237,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:14.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":102163,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, January 7, 2019, December 14, 2017, December 13, 2016 and May 2, 2016 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":102163,"derivative":{"exercise_price":1.28,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":102163},"source":{"system":"sec-edgar","filing":"0001493152-20-022149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022149/ownership.xml","form_type":"4"}},{"id":2972236,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:14.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":57837,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, January 7, 2019, December 14, 2017, December 13, 2016 and May 2, 2016 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":3.2,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":57837},"source":{"system":"sec-edgar","filing":"0001493152-20-022149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022149/ownership.xml","form_type":"4"}},{"id":2972235,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:14.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":57837,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, January 7, 2019, December 14, 2017, December 13, 2016 and May 2, 2016 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":57837,"derivative":{"exercise_price":1.28,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":57837},"source":{"system":"sec-edgar","filing":"0001493152-20-022149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022149/ownership.xml","form_type":"4"}},{"id":3138314,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-05-22T22:17:26.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":57837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":57837,"derivative":{"exercise_price":3.2,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":57837},"source":{"system":"sec-edgar","filing":"0001493152-20-009766","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220009766/ownership.xml","form_type":"4"}},{"id":3138313,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-22T22:17:26.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest 25% on March 31, 2021, and in three equal annual installments thereafter."}],"balance_after":80000,"source":{"system":"sec-edgar","filing":"0001493152-20-009766","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220009766/ownership.xml","form_type":"4"}},{"id":3203727,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-18T20:35:34.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":102163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Contingent upon stockholder approval of an amendment to the 2015 Equity Incentive Plan (the \"2015 Plan\") at the Annual Meeting of Stockholders scheduled for May 20, 2020 to increase the number of shares available under the 2015 Plan, Ms. Silverstein will also be entitled to an additional grant of 57,837 stock options and a grant of 80,000 shares of restricted stock as soon as practicable after the amendment of the 2015 Plan. The stock options contingent upon stockholder approval will have an exercise price determined at the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":102163,"derivative":{"exercise_price":1.45,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":102163},"source":{"system":"sec-edgar","filing":"0001493152-20-004254","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220004254/ownership.xml","form_type":"4"}},{"id":3553081,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-18T21:58:22.000Z","date":"2019-01-07","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest 25% on January 7, 2020, and in 36 equal monthly installments thereafter."}],"balance_after":20000,"derivative":{"exercise_price":7.02,"expiration_date":"2029-01-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-19-020316","document":"tv519201_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000114420419020316/tv519201_4.xml","form_type":"4"}},{"id":3558037,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38421,"kind":"person","name":"Silverstein Christine Berni","position":1,"cik":"0001772546","reported_name":"Silverstein Christine Berni","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-11T22:52:23.000Z","date":"2019-04-09","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter."}],"balance_after":80000,"derivative":{"exercise_price":7.24,"expiration_date":"2029-04-09","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001144204-19-019348","document":"tv518743_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000114420419019348/tv518743_4.xml","form_type":"4"}}]}